[1]
M. Agnarsdóttir, H. Päären, and I. Vassilaki, “The impact of standardized care pathway on reporting time for invasive melanoma – results from one pathology department in Sweden”, ujms, vol. 124, no. 4, pp. 260–264, Oct. 2019.